SurModics (SRDX) Tops Q3 EPS by 7c, suspends previous guidance
Tweet
Share
E-mailGet Alerts SRDX Hot Sheet
Price: $42.98 --0%
Financial Fact:
Selling, general and administrative: 5.02M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Financial Fact:
Selling, general and administrative: 5.02M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
SurModics (NASDAQ: SRDX) reported Q3 EPS of ($0.27), $0.07 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $30.3 million versus the consensus estimate of $29.95 million.
Fiscal Year 2024 Financial Guidance
Surmodics is suspending its previously issued financial guidance for fiscal 2024 in light of the pending acquisition by GTCR.
For earnings history and earnings-related data on SurModics (SRDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- Ximen Mining launches $350,000 bridge placement for Kenville mine
- Generation Income Properties Enters Into Warrant Exercise Transaction for $4.3 Million in Gross Proceeds
Create E-mail Alert Related Categories
EarningsRelated Entities
GTCR, Earnings, Definitive Agreement, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
